Read + Share
Eskazan AE. Plasma imatinib trough levels for predicting efficacy and toxicity in patients
with chronic myeloid leukemia in chronic phase: Still a matter of debate! Cancer 2022 Dec 8. doi: 10.1002/cncr.34577.
PMID: 36477711
|
 |
|
Eskazan AE. Plasma imatinib trough levels for predicting efficacy and toxicity in patients
with chronic myeloid leukemia in chronic phase: Still a matter of debate! Cancer 2022 Dec 8. doi: 10.1002/cncr.34577.
PMID: 36477711
|
|
|
|